Large prospective cohorts should examine interactions between obesity-related genetic polymorphisms (e.g., CYP19A1, PTEN, PIK3CA), adipokine expression profiles, and metabolomic signatures to delineate high-risk phenotypes requiring intensified preventive surveillance. The gene discussed is PTEN; the disease is obesity due to melanocortin 4 receptor deficiency.